Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 201.69
+4.02 (2.03%)
Oct 10, 2025, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 267.81 billion as of October 10, 2025. Its market cap has decreased by -8.82% in one year.
Market Cap
267.81B
Enterprise Value
312.29B
Revenue
91.34B
Ranking
n/a
PE Ratio
275.20
Stock Price
201.69
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 267.81B, an increase of 18.12%. That is a compound annual growth rate of 5.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 267.81B | -24.13% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,009.05B |
| Divi's Laboratories | 1,718.78B |
| Cipla | 1,261.57B |
| Apollo Hospitals Enterprise | 1,104.41B |
| Mankind Pharma | 1,015.34B |
| Zydus Lifesciences | 999.64B |
| Fortis Healthcare | 800.48B |
| Aurobindo Pharma | 656.48B |